Skip to search.
 TSX Up 0.14% TSX Ventures Up 0.27%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
95.11 Down 1.94(1.99%) 11:24AM EDT - Nasdaq Real Time Price
Prev Close:97.05
Open:96.93
Bid:94.88 x 100
Ask:95.02 x 200
1y Target Est:119.06
Beta:1.73698
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:94.76 - 97.47
52wk Range:62.12 - 118.48
Volume:369,233
Avg Vol (3m):1,792,120
Market Cap:16.24B
P/E (ttm):N/A
EPS (ttm):-3.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 1.99%16.24B
FOLDDown 2.82%1.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.95
Quarterly EPS Est (Sep-16) :-0.38
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback